Your browser doesn't support javascript.
loading
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Rondy, Marc; Larrauri, Amparo; Casado, Itziar; Alfonsi, Valeria; Pitigoi, Daniela; Launay, Odile; Syrjänen, Ritva K; Gefenaite, Giedre; Machado, Ausenda; Vucina, Vesna Visekruna; Horváth, Judith Krisztina; Paradowska-Stankiewicz, Iwona; Marbus, Sierk D; Gherasim, Alin; Díaz-González, Jorge Alberto; Rizzo, Caterina; Ivanciuc, Alina E; Galtier, Florence; Ikonen, Niina; Mickiene, Aukse; Gomez, Veronica; Kurecic Filipovic, Sanja; Ferenczi, Annamária; Korcinska, Monika R; van Gageldonk-Lafeber, Rianne; Valenciano, Marta.
Afiliação
  • Rondy M; EpiConcept, Paris, France.
  • Larrauri A; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.
  • Casado I; CIBER Epidemiología y Salud Pública, Institute of Health Carlos III, Madrid, Spain.
  • Alfonsi V; CIBER Epidemiología y Salud Pública, Institute of Health Carlos III, Madrid, Spain.
  • Pitigoi D; Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.
  • Launay O; Istituto Superiore di Sanità, Rome, Italy.
  • Syrjänen RK; UMF Carol Davila, INC Cantacuzino, Bucharest, Romania.
  • Gefenaite G; Inserm, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France.
  • Machado A; Université Paris Descartes, Sorbonne Paris Cité, APHP, CIC Cochin-Pasteur, Paris, France.
  • Vucina VV; Impact Assessment Unit, National Institute for Health and Welfare, Tampere, Finland.
  • Horváth JK; Department of Infectious diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Paradowska-Stankiewicz I; Epidemiology Research Unit, Epidemiology Department, National Health Institute Dr Ricardo Jorge, Lisbon, Portugal.
  • Marbus SD; Epidemiology Service, Croatian Institute of Public Health, Zagreb, Croatia.
  • Gherasim A; Office of the Chief Medical Officer, Budapest, Hungary.
  • Díaz-González JA; National institute of Public Health - National Institute of Hygiene, Department of Epidemiology, Warsaw, Poland.
  • Rizzo C; Centre for Epidemiology and surveillance of infectious diseases, Centre for infectious disease control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Ivanciuc AE; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.
  • Galtier F; CIBER Epidemiología y Salud Pública, Institute of Health Carlos III, Madrid, Spain.
  • Ikonen N; Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.
  • Mickiene A; Istituto Superiore di Sanità, Rome, Italy.
  • Gomez V; INC Cantacuzino, Bucharest, Romania.
  • Kurecic Filipovic S; Inserm, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France.
  • Ferenczi A; CIC de Montpellier, Hôpital Saint-Eloi, CHU de Montpellier, Montpellier, France.
  • Korcinska MR; Viral Infections Unit, National Institute for Health and Welfare, Helsinki, Finland.
  • van Gageldonk-Lafeber R; Department of Infectious diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Valenciano M; Epidemiology Service, Croatian Institute of Public Health, Zagreb, Croatia.
Euro Surveill ; 22(30)2017 07 27.
Article em En | MEDLINE | ID: mdl-28797322
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Potência de Vacina / Hospitalização Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Potência de Vacina / Hospitalização Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article